136 related articles for article (PubMed ID: 18646355)
1. Thyroid-stimulating hormone and follicle-stimulating hormone status in Hispanic women during the menopause transition.
Rojas LV; Nieves K; Suarez E; Ortiz AP; Rivera A; Romaguera J
Ethn Dis; 2008; 18(2 Suppl 2):S2-230-4. PubMed ID: 18646355
[TBL] [Abstract][Full Text] [Related]
2. Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN.
Sowers M; Luborsky J; Perdue C; Araujo KL; Goldman MB; Harlow SD;
Clin Endocrinol (Oxf); 2003 Mar; 58(3):340-7. PubMed ID: 12608940
[TBL] [Abstract][Full Text] [Related]
3. Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999-2000)*.
Henrich JB; Hughes JP; Kaufman SC; Brody DJ; Curtin LR
Menopause; 2006; 13(2):171-7. PubMed ID: 16645530
[TBL] [Abstract][Full Text] [Related]
4. Hormone profile of menopausal women in Havana.
Navarro D; Acosta A; Robles E; Díaz C
MEDICC Rev; 2012 Apr; 14(2):13-5. PubMed ID: 22580548
[TBL] [Abstract][Full Text] [Related]
5. The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women.
Morris MS
Bone; 2007 Apr; 40(4):1128-34. PubMed ID: 17236836
[TBL] [Abstract][Full Text] [Related]
6. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
7. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay for human follicle-stimulating hormone: physiological studies.
Odell WD; Parlow AF; Cargille CM; Ross GT
J Clin Invest; 1968 Dec; 47(12):2551-62. PubMed ID: 5725274
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of postmenopausal-like acidic follicle-stimulating hormone (FSH) isoforms precedes the rise of FSH before menopause.
Thomas CM; Span PN; Smeenk JM; Hanssen RG; Braat DD; Sweep FC
Fertil Steril; 2009 Aug; 92(2):613-9. PubMed ID: 18692804
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of pulsatile and copulsatile release of thyroid-stimulating hormone, luteinizing hormone, follicle-stimulating hormone, and alpha-subunit.
Samuels MH; Veldhuis JD; Henry P; Ridgway EC
J Clin Endocrinol Metab; 1990 Aug; 71(2):425-32. PubMed ID: 1696277
[TBL] [Abstract][Full Text] [Related]
11. Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease.
Magri F; Capelli V; Gaiti M; Brambilla E; Montesion L; Rotondi M; Spinillo A; Nappi RE; Chiovato L
Thyroid; 2013 Oct; 23(10):1312-8. PubMed ID: 23556516
[TBL] [Abstract][Full Text] [Related]
12. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
Ausmanas MK; Tan DA; Jaisamrarn U; Tian XW; Holinka CF
Climacteric; 2007 Oct; 10(5):427-37. PubMed ID: 17852146
[TBL] [Abstract][Full Text] [Related]
13. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN).
Luetters C; Huang MH; Seeman T; Buckwalter G; Meyer PM; Avis NE; Sternfeld B; Johnston JM; Greendale GA
J Womens Health (Larchmt); 2007 Apr; 16(3):331-44. PubMed ID: 17439378
[TBL] [Abstract][Full Text] [Related]
14. Serum follicle stimulating hormone is associated with reduced risk of diabetes in postmenopausal women: The Hong Kong osteoporosis study.
Cheung CL; Kung AWC; Tan KCB
Maturitas; 2018 Aug; 114():41-45. PubMed ID: 29907245
[TBL] [Abstract][Full Text] [Related]
15. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
[TBL] [Abstract][Full Text] [Related]
16. Serum Follicle-Stimulating Hormone and 5-Year Change in Adiposity in Healthy Postmenopausal Women.
Mattick LJ; Bea JW; Singh L; Hovey KM; Banack HR; Wactawski-Wende J; Manson JE; Funk JL; Ochs-Balcom HM
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3455-e3462. PubMed ID: 35435955
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of FSH measurements for determining menopause in long-term users of depot medroxyprogesterone acetate over 40 years of age.
Juliato CT; Fernandes A; Marchi NM; Castro S; Olivotti B; Bahamondes L
Contraception; 2007 Oct; 76(4):282-6. PubMed ID: 17900438
[TBL] [Abstract][Full Text] [Related]
18. High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women.
Li Q; Zheng D; Lin H; Zhong F; Liu J; Wu Y; Wang Z; Guan Q; Zhao M; Gao L; Zhao J
Front Endocrinol (Lausanne); 2021; 12():627903. PubMed ID: 33868168
[TBL] [Abstract][Full Text] [Related]
19. Androgens and estrogens in relation to hot flushes during the menopausal transition.
Øverlie I; Moen MH; Holte A; Finset A
Maturitas; 2002 Jan; 41(1):69-77. PubMed ID: 11809345
[TBL] [Abstract][Full Text] [Related]
20. Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.
Du YJ; Xin X; Cui N; Jiang L; Yang AM; Hao GM; Gao BL
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():207-212. PubMed ID: 30731333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
